Category: Press Release - Part 3

WAYNE, PA, December 6, 2004 — Safeguard Scientifics, Inc. (NYSE: SFE) announced today that it had completed the acquisition of the business and substantially all of the assets of Laureate Pharma L.P. of Princeton, NJ for approximately $29.5 million. Laureate Pharma is a bioprocessing and drug delivery services company dedicated to supporting the development and commercialization of new pharmaceuticals and diagnostics. Anthony L. Craig, President and Chief Executive Officer of…

PRINCETON, NJ – June 3, 2004 – Laureate Pharma L.P. announces its recently installed 2500-Liter stirred tank bioreactor is validated and fully operational. The bioreactor, with an overall working volume of 2000-Liters, has been installed in a new cGMP production suite, extensively validated and suitable for cGMP manufacture of kilogram quantities of biopharmaceutical products such as monoclonal antibodies and other recombinant proteins. In addition, Laureate has increased the capacities of…

FRAMINGHAM, MA and PRINCETON, NJ – March 9, 2004 — GTC Biotherapeutics, Inc. (“GTC”, Nasdaq: GTCB) and Laureate Pharma L.P. (“Laureate Pharma”) have entered into a strategic collaboration for serving the clinical and commercial development, production, and purification needs of the biopharmaceutical industry. GTC and Laureate Pharma will coordinate their industry marketing efforts to provide strategic access to clients for recombinant protein production services required from small scale through tonnage…

PRINCETON, NJ – January 21, 2004 – Laureate Pharma L.P. announces entering into a manufacturing agreement with Discovery Laboratories, Inc. Under the contract, Laureate Pharma will provide manufacturing services that support Discovery Laboratories’ product requirements. Terms of the agreement were not disclosed. In the first phase of the manufacturing implementation plan, Discovery has transferred its existing manufacturing equipment to Laureate’s microparticle manufacturing facility located in Totowa, N.J. Project plans include…

PRINCETON, NJ – October 14, 2003 – Laureate Pharma L.P. and FeRx, Inc. announce a manufacturing and services agreement for FeRx Incorporated’s MTC-DOX product. Under the contract, Laureate Pharma will provide formulation and filling services to support FeRx’s clinical development programs. Terms of the agreement were not disclosed. “We are delighted to be working with FeRx. There is an excellent fit between FeRx’s technology and Laureate’s capabilities in microparticle manufacturing,”…

PRINCETON, NJ – June 17, 2003 – Laureate Pharma L.P. announces the expansion of its purification capacity with the commissioning of a new automated chromatography system for GMP purification of protein products. The unit is specifically designed for biopharmaceutical purification applications, featuring polymeric, sanitary flowpaths and an array of detectors. In the coming months, the company anticipates installation and validation of an identically configured larger scale chromatography system to purify…

PRINCETON, NJ – May 14, 2003 – Laureate Pharma L.P. announces its recently installed 200-Liter working volume stirred tank bioreactor is now operational and fully validated. Laureate, a privately held contract manufacturing company, offers full services to clients requiring development and production of monoclonal antibody products and other recombinant protein products expressed using mammalian cell culture. Later this year, installation of a 2000-Liter working volume stirred tank bioreactor will be…

PRINCETON, NJ – March 26, 2003 – Laureate Pharma L.P. and TolerRx, Inc. announce a second biopharmaceutical manufacturing and services agreement for TolerRx’s therapeutic monoclonal antibody pipeline. Under the contract, Laureate Pharma will provide purification and aseptic filling services to support TolerRx’s clinical trials. Terms of the agreement were not disclosed. “We are delighted to continue working with TolerRx. There is an excellent fit between TolerRx’s antibody therapeutics and Laureate’s…

Princeton, NJ – January 7, 2003 – Laureate Pharma L.P. today announced the appointment of Lawrence W. Chakrin, Ph.D. as a new member of its Board of Directors. Dr. Chakrin is Corporate Vice President of Science Applications International Corporation (SAIC), the largest employee-owned research and engineering firm in the United States, where he is responsible for corporate development of SAIC’s Biomedical Research Group. Before joining SAIC, Dr. Chakrin was a…

Princeton, NJ – December 5, 2002 – Laureate Pharma L.P. announced the appointment of Stan Zeichner as Director, Sales & Marketing. Reporting to Robert J. Broeze, Ph.D., President, he is responsible for all aspects of sales and marketing for the company. “We are delighted to welcome Stan to our management team,” said Robert J. Broeze, Ph.D., President of Laureate Pharma L.P. “His more than 20 years experience in sales and…